Redefining standards: Improving community-reflective practices in dermatology clinical trials
The publisher did not provide an abstract — full text is available via the link below.
The publisher did not provide an abstract — full text is available via the link below.
Nature Medicine, Published online: 20 November 2026; doi:10.1038/s41591-026-04781-0 Concerns about use of placebo control in clinical trials of Obinutuzumab β for aquaporin-4 antibody positive neuromyelitis optica spectrum disorder
Nature Medicine, Published online: 20 November 2026; doi:10.1038/s41591-026-04782-z Reply to: Concerns about use of placebo control in clinical trials of Obinutuzumab β for aquaporin-4 antibody positive neuromyelitis optica spectrum disorder